| 利用者成果(英) |
|
17802
Tsuchiya M, Kong W, Hiraoka Y, Haraguchi T, Ogawa H.
TBK1 inhibitors enhance transfection efficiency by suppressing p62/SQSTM1 phosphorylation
Genes Cells
2023
28(1):68-77
PubMed ID: 36284367
DOI: 10.1111/gtc.12987
|
|
16838
Matsushita M, Fujita K, Hatano K, Hayashi T, Kayama H, Motooka D, Hase H, Yamamoto A, Uemura T, Yamamichi G, Tomiyama E, Koh Y, Kato T, Kawashima A, Uemura M, Nojima S, Imamura R, Mubeen A, Netto GJ, Tsujikawa K, Nakamura S, Takeda K, Morii E, Nonomura N.
High-fat diet promotes prostate cancer growth through histamine signaling
Int J Cancer
2022
151(4):623-636
PubMed ID: 35403732
DOI: 10.1002/ijc.34028
|
|
20799
Fujimoto M, Takii R, Matsumoto M, Okada M, Nakayama KI, Nakato R, Fujiki K, Shirahige K, Nakai A.
HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.
Nat Commun
2022
13(1):4355
PubMed ID: 35906200
DOI: 10.1038/s41467-022-32034-4
|
|
20927
Nakamura M, Fujiwara K, Doi N.
Cytoplasmic delivery of siRNA using human-derived membrane penetration-enhancing peptide.
J Nanobiotechnology
2022
20(1):458
PubMed ID: 36303212
DOI: 10.1186/s12951-022-01667-4
|
|
17315
Watabe T, Kaneda-Nakashima K, Shirakami Y, Kadonaga Y, Ooe K, Wang Y, Haba H, Toyoshima A, Cardinale J, Giesel FL, Tomiyama N, Fukase K.
Targeted α-therapy using astatine (211At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound
Eur J Nucl Med Mol Imaging
2022
Nov 8
PubMed ID: 36344651
DOI: 10.1007/s00259-022-06016-z
|
|
20988
Naito M, Ikeda K, Aoyama S, Kanamoto M, Akasaka Y, Kido Y, Nakanishi M, Kanna M, Yamamotoya T, Matsubara A, Hinata N, Asano T, Nakatsu Y.
Par14 interacts with the androgen receptor, augmenting both its transcriptional activity and prostate cancer proliferation.
Cancer Med
2022
PubMed ID: 36583514
DOI: 10.1002/cam4.5587
|
|
13130
Sasaki K, Harada M, Yoshikawa T, Tagawa H, Harada Y, Yonemitsu Y, Ryujin T, Kishimura A, Mori T, Katayama Y.
Fc-Binding Antibody-Recruiting Molecules Targeting Prostate-Specific Membrane Antigen: Defucosylation of Antibody for Efficacy Improvement*.
Chembiochem
2021
22(3):496-500
PubMed ID: 32969164
DOI: 10.1002/cbic.202000577
|
|
13393
Miyasaka K, Takeda S, Nakamura S, Matsuda H, Shimoda H.
Estrogenic and antiandrogenic activities of methoxyflavans isolated from the fruit of Mauritia Flexuosa (Moriche Palm).
J Food Biochem
2021
PubMed ID: 33340139
DOI: 10.1111/jfbc.13583
|
|
20249
Makise M, Uchimura R, Higashi K, Mashiki Y, Shiraishi R, Shutoku Y, Kuniyasu A.
Overexpression of the nucleoporin Nup88 stimulates migration and invasion of HeLa cells.
Histochem Cell Biol
2021
PubMed ID: 34331103
DOI: 10.1007/s00418-021-02020-w
|
|
15709
Heishima K, Sugito N, Soga T, Nishikawa M, Ito Y, Honda R, Kuranaga Y, Sakai H, Ito R, Nakagawa T, Ueda H, Akao Y.
Petasin potently inhibits mitochondrial complex I-based metabolism that supports tumor growth and metastasis
J Clin Invest
2021
131(17):e139933
PubMed ID: 34623325
DOI: 10.1172/JCI139933
|
|
20406
Sawa C, Yofu S, Kiriyama K, Sutoh K, Saito T, Kishi S, Gunji M, Inoue Y, Sugi M, Shioda S, Honda K.
High concentration of extracellular nucleotides suppresses cell growth via delayed cell cycle progression in cancer and noncancer cell lines.
Heliyon
2021
7(11):e08318
PubMed ID: 34816032
DOI: 10.1016/j.heliyon.2021.e08318
|
|
16986
Nishimura K, Mori J, Sawada T, Nomura S, Kouzmenko A, Yamashita K, Kanemoto Y, Kurokawa T, Hayakawa A, Tokiwa S, Ochi M, Shimmura H, Kato S.
Profiling of Androgen-Dependent Enhancer RNAs Expression in Human Prostate Tumors: Search for Malignancy Transition Markers
Res Rep Urol
2021
13:705-713
PubMed ID: 34549035
DOI: 10.2147/RRU.S328661
|
|
17035
Ohya S, Kajikuri J, Endo K, Kito H, Matsui M.
K Ca 1.1 K + Channel Inhibition Overcomes Resistance to Antiandrogens and Doxorubicin in a Human Prostate Cancer LNCaP Spheroid Model
Int J Mol Sci
2021
22(24):13553
PubMed ID: 34948357
DOI: 10.3390/ijms222413553
|
|
12056
Ideo H, Kondo J, Nomura T, Nonomura N, Inoue M, Amano J.
Study of glycosylation of prostate-specific antigen secreted by cancer tissue-originated spheroids reveals new candidates for prostate cancer detection.
Sci Rep
2020
PubMed ID: 32066783
DOI: 10.1038/s41598-020-59622-y
|
|
13264
Hikita T, Miyata M, Watanabe R, Oneyama C.
In vivo imaging of long-term accumulation of cancer-derived exosomes using a BRET-based reporter.
Sci Rep
2020
PubMed ID: 33024173
DOI: 10.1038/s41598-020-73580-5
|
|
13317
Fujita K, Kamiya M, Yoshioka T, Ogasawara A, Hino R, Kojima R, Ueo H, Urano Y.
Rapid and Accurate Visualization of Breast Tumors with a Fluorescent Probe Targeting α-Mannosidase 2C1.
ACS Cent Sci
2020
PubMed ID: 33376783
DOI: 10.1021/acscentsci.0c01189
|
|
13591
Saiki I, Yara M, Yamanaka T, Uchino H, Inazu M.
Functional Expression of Choline Transporter-Like Protein 1 in LNCaP Prostate Cancer Cells: A Novel Molecular Target
Biomol Ther (Seoul)
2020
28(2):195-201
PubMed ID: 31693854
DOI: 10.4062/biomolther.2019.097
|
|
14832
Saito S, Kitamura-Muramatsu Y, Komine F, Polat M, Takeshima SN, Takei M, Aida Y.
Absence of bovine leukemia virus proviral DNA in Japanese human blood cell lines and human cancer cell lines
Arch Virol
2020
165(1):207-214
PubMed ID: 31776677
DOI: 10.1007/s00705-019-04474-9
|
|
11446
Wada A, Terashima T, Kageyama S, Yoshida T, Narita M, Kawauchi A, Kojima H.
Efficient Prostate Cancer Therapy with Tissue-Specific Homing Peptides Identified by Advanced Phage Display Technology.
Mol Ther Oncolytics
2019
PubMed ID: 30788426
DOI: 10.1016/j.omto.2019.01.001
|
|
11507
Murata K, Saga R, Monzen S, Tsuruga E, Hasegawa K, Hosokawa Y.
Understanding the mechanism underlying the acquisition of radioresistance in human prostate cancer cells.
Oncol Lett
2019
PubMed ID: 31186811
DOI: 10.3892/ol.2019.10219
|
|
11533
Saga R, Matsuya Y, Takahashi R, Hasegawa K, Date H, Hosokawa Y.
Analysis of the high-dose-range radioresistance of prostate cancer cells, including cancer stem cells, based on a stochastic model.
J. Radiat. Res.
2019
PubMed ID: 31034058
DOI: 10.1093/jrr/rrz011
|
|
11591
Kawatani M, Yamamoto K, Yamada D, Kamiya M, Miyakawa J, Miyama Y, Kojima R, Morikawa T, Kume H, Urano Y.
Fluorescence Detection of Prostate Cancer by an Activatable Fluorescence Probe for PSMA Carboxypeptidase Activity.
J. Am. Chem. Soc.
2019
PubMed ID: 31244179
DOI: 10.1021/jacs.9b04412
|
|
11800
Koizumi A, Narita S, Nakanishi H, Ishikawa M, Eguchi S, Kimura H, Takasuga S, Huang M, Inoue T, Sasaki J, Yoshioka T, Habuchi T, Sasaki T.
Increased fatty acyl saturation of phosphatidylinositol phosphates in prostate cancer progression.
Sci Rep
2019
PubMed ID: 31520002
DOI: 10.1038/s41598-019-49744-3
|
|
11807
Takagi H, Ii H, Kageyama S, Hanada E, Taniguchi K, Yoshiya T, Chano T, Kawauchi A, Nakata S.
Blockade of γ-Glutamylcyclotransferase Enhances Docetaxel Growth Inhibition of Prostate Cancer Cells.
Anticancer Res.
2019
PubMed ID: 31519583
DOI: 10.21873/anticanres.13666
|
|
6922
Soeda F, Watabe T, Naka S, Liu Y, Horitsugi G, Neels OC, Kopka K, Tatsumi M, Shimosegawa E, Giesel FL, Hatazawa J.
Impact of 18F-PSMA-1007 Uptake in Prostate Cancer Using Different Peptide Concentrations: Preclinical PET/CT Study on Mice.
J Nucl Med
2019
60(11):1594-1599
PubMed ID: 30902876
DOI: 10.2967/jnumed.118.223479
|
|
9810
Junko Shibato, Fumiko Takenoya, Takahiro Hirabayashi, Ai Kimura, Yusuke Iwasaki, Yoko Toyoda, Motohide Hori, Shigeru Tamogami, Randeep Rakwal, Seiji Shioda
Towards Identification of Bioactive Compounds in Cold Vacuum Extracted Double Cherry Blossom (Gosen-Sakura) Leaves
Plant Signal Behav
2019
14(10):e1644594
PubMed ID: 31342859
DOI: 10.1080/15592324.2019.1644594
|
|
12506
Jin C, Zhao W, Zhang Z, Liu W.
Silencing circular RNA circZNF609 restrains growth, migration and invasion by up-regulating microRNA-186-5p in prostate cancer
Artif Cells Nanomed Biotechnol
2019
47(1):3350-3358
PubMed ID: 31387394
DOI: 10.1080/21691401.2019.1648281
|
|
11152
Kamei H, Noguchi K, Matsuda H, Murata K.
Screening of Euphorbiaceae Plant Extracts for Anti-5α-reductase.
Biol. Pharm. Bull.
2018
41(8):1307-1310
PubMed ID: 30068884
DOI: 10.1248/bpb.b18-00283
|
|
11156
Ito S, Kayukawa N, Ueda T, Taniguchi H, Morioka Y, Hongo F, Ukimura O.
MRGBP promotes AR-mediated transactivation of KLK3 and TMPRSS2 via acetylation of histone H2A.Z in prostate cancer cells.
Biochim Biophys Acta Gene Regul Mech
2018
PubMed ID: 30076933
DOI: 10.1016/j.bbagrm.2018.07.014
|
|
11160
Languon S, Tuffour I, Quayson EE, Appiah-Opong R, Quaye O.
In Vitro Evaluation of Cytotoxic Activities of Marketed Herbal Products in Ghana.
J Evid Based Integr Med
2018
PubMed ID: 30088418
DOI: 10.1177/2515690X18790723
|
|
4279
Ito S, Ueno A, Ueda T, Nakagawa H, Taniguchi H, Kayukawa N, Fujihara-Iwata A, Hongo F, Okihara K, Ukimura O.
CNPY2 inhibits MYLIP-mediated AR protein degradation in prostate cancer cells.
Oncotarget
2018
PubMed ID: 29707137
DOI: 10.18632/oncotarget.24824
|
|
14599
Senga S, Kawaguchi K, Kobayashi N, Ando A, Fujii H.
A novel fatty acid-binding protein 5-estrogen-related receptor α signaling pathway promotes cell growth and energy metabolism in prostate cancer cells
Oncotarget
2018
9(60):31753-31770
PubMed ID: 30167092
DOI: 10.18632/oncotarget.25878
|
|
10057
Li X, Wang X, Zhang J, Hanagata N, Wang X, Weng Q, Ito A, Bando Y, Golberg D.
Hollow boron nitride nanospheres as boron reservoir for prostate cancer treatment.
Nat Commun
2017
8:13936
PubMed ID: 28059072
DOI: 10.1038/ncomms13936
|
|
10403
Qin H, Rasul A, Li X, Masood M, Yang G, Wang N, Wei W, He X, Watanabe N, Li J, Li X.
CD147-induced cell proliferation is associated with Smad4 signal inhibition.
Exp. Cell Res.
2017
358:279-289
PubMed ID: 28684116
DOI: 10.1016/j.yexcr.2017.07.003
|
|
10514
Kanayama M, Hayano T, Koebis M, Maeda T, Tabe Y, Horie S, Aiba A.
Hyperactive mTOR induces neuroendocrine differentiation in prostate cancer cell with concurrent up-regulation of IRF1.
Prostate
2017
77:1489-1498
PubMed ID: 28905415
DOI: 10.1002/pros.23425
|
|
11072
Hagiwara K, Tobisawa Y, Kaya T, Kaneko T, Hatakeyama S, Mori K, Hashimoto Y, Koie T, Suda Y, Ohyama C, Yoneyama T.
Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.
Int J Mol Sci
2017
PubMed ID: 28134773
DOI: 10.3390/ijms18020261
|
|
4534
Cui C, Hanyu M, Hatori A, Zhang Y, Xie L, Ohya T, Fukada M, Suzuki H, Nagatsu K, Jiang C, Luo R, Shao G, Zhang M, Wang F.
Synthesis and evaluation of [64Cu]PSMA-617 targeted for prostate-specific membrane antigen in prostate cancer.
Am J Nucl Med Mol Imaging
2017
7(2):40-52
PubMed ID: 28533936
|
|
14781
Fukami K, Asano E, Ueda M, Sekiguchi F, Yoshida S, Kawabata A.
High glucose induces N-linked glycosylation-mediated functional upregulation and overexpression of Ca v 3.2 T-type calcium channels in neuroendocrine-like differentiated human prostate cancer cells
J Pharmacol Sci
2017
133(1):57-6
PubMed ID: 28081948
DOI: 10.1016/j.jphs.2016.12.004
|
|
9650
Ogura T, Tanaka Y, Tamaki H, Harada M.
Docetaxel induces Bcl-2- and pro-apoptotic caspase-independent death of human prostate cancer DU145 cells.
Int. J. Oncol.
2016
48:2330-8
PubMed ID: 27082738
DOI: 10.3892/ijo.2016.3482
|
|
9862
Sakura Y, Tsuboi K, Uyama T, Zhang X, Taoka R, Sugimoto M, Kakehi Y, Ueda N.
A quantitative study on splice variants of N-acylethanolamine acid amidase in human prostate cancer cells and other cells.
Biochim. Biophys. Acta
2016
1861:1951-1958
PubMed ID: 27693242
DOI: 10.1016/j.bbalip.2016.09.018
|
|
9868
Ito H, Yamaguchi N, Onimaru M, Kimura S, Ohmori T, Ishikawa F, Sato J, Ito S, Inoue H.
Change in number and size of circulating tumor cells with high telomerase activity during treatment of patients with gastric cancer.
Oncol Lett
2016
12:4720-4726
PubMed ID: 28105179
DOI: 10.3892/ol.2016.5239
|
|
10024
Matsumura K, Nakata S, Taniguchi K, Ii H, Ashihara E, Kageyama S, Kawauchi A, Yoshiki T.
Depletion of γ-glutamylcyclotransferase inhibits breast cancer cell growth via cellular senescence induction mediated by CDK inhibitor upregulation.
BMC Cancer
2016
16:748
PubMed ID: 27658708
DOI: 10.1186/s12885-016-2779-y
|
|
10905
Roasted coffee induction of aldo-keto reductase 1C3 expression in LNCaP human prostate cancer cells is associated with Nrf2 activation
Oncology Letters
2016
12, 5321-5326
DOI: 10.3892/ol.2016.5334
|
|
12204
Minhui Xu, Shinichi Sakamoto, Jun Matsushima, Toru Kimura, Takeshi Ueda, Atsushi Mizokami, Yoshikatsu Kanai, Tomohiko Ichikawa
Up-Regulation of LAT1 during Antiandrogen Therapy Contributes to Progression in Prostate Cancer Cells
J Urol
2016
195(5):1588-1597
PubMed ID: 26682754
DOI: 10.1016/j.juro.2015.11.071
|
|
12621
Okada T, Uto K, Aoyagi T, Ebara M.
A biomimetic approach to hormone resistant prostate cancer cell isolation using inactivated Sendai virus (HVJ-E)
Biomater Sci
2016
4(1):96-103
PubMed ID: 26553555
DOI: 10.1039/c5bm00375j
|
|
12637
Kawaguchi K, Kinameri A, Suzuki S, Senga S, Ke Y, Fujii H.
The cancer-promoting gene fatty acid-binding protein 5 (FABP5) is epigenetically regulated during human prostate carcinogenesis
Biochem J
2016
473(4):449-61
PubMed ID: 26614767
DOI: 10.1042/BJ20150926
|
|
12660
Thangavel S, Yoshitomi T, Sakharkar MK, Nagasaki Y.
Redox nanoparticle increases the chemotherapeutic efficiency of pioglitazone and suppresses its toxic side effects
Biomaterials
2016
99:109-23
PubMed ID: 27235996
DOI: 10.1016/j.biomaterials.2016.05.001
|
|
12683
Matsushita S, Suzuki K, Ogino Y, Hino S, Sato T, Suyama M, Matsumoto T, Omori A, Inoue S, Yamada G.
Androgen Regulates Mafb Expression Through its 3'UTR During Mouse Urethral Masculinization
Endocrinology
2016
157(2):844-57.
PubMed ID: 26636186
DOI: 10.1210/en.2015-1586
|
|
14128
REGINA APPIAH-OPONG, ISAAC KWADWO ASANTE, DORCAS OSEI SAFO, ISAAC TUFFOUR, EBENEZER OFORI- ATTAH, TAKUHIRO UTO, ALEXANDER KWADWO NYARKO
Cytotoxic effects of Albizia zygia (DC) JF Macbr, a Ghanaian medicinal plant, against human T-lymphoblast-like leukemia, prostate and breast cancer cell lines
International Journal of Pharmacy and Pharmaceutical Sciences
2016
8
|
|
15159
Honda S, Loher P, Shigematsu M, Palazzo JP, Suzuki R, Imoto I, Rigoutsos I, Kirino Y.
Sex hormone-dependent tRNA halves enhance cell proliferation in breast and prostate cancers
Proc Natl Acad Sci U S A
2015
112(29):E3816-25
PubMed ID: 26124144
DOI: 10.1073/pnas.1510077112
|
|
15450
Fukami K, Sekiguchi F, Yasukawa M, Asano E, Kasamatsu R, Ueda M, Yoshida S, Kawabata A.
Functional upregulation of the H2S/Cav3.2 channel pathway accelerates secretory function in neuroendocrine-differentiated human prostate cancer cells
Biochem Pharmacol
2015
97(3):300-9
PubMed ID: 26256074
DOI: 10.1016/j.bcp.2015.08.005
|
|
6398
Nagano K, Yamashita T, Inoue M, Higashisaka K, Yoshioka Y, Abe Y, Mukai Y, Kamada H, Tsutsumi Y, Tsunoda S
Eph receptor A10 has a potential as a target for a prostate cancer therapy.
Biochem Biophys Res Commun
2014
450(1):545-9
PubMed ID: 24924629
DOI: 10.1016/j.bbrc.2014.06.007
|
|
7747
Qin XY, Zaha H, Nagano R, Yoshinaga J, Yonemoto J, Sone H.
Xenoestrogens down-regulate aryl-hydrocarbon receptor nuclear translocator 2 mRNA expression in human breast cancer cells via an estrogen receptor alpha-dependent mechanism.
Toxicol. Lett.
2011
206:152-7
PubMed ID: 21771643
DOI: 10.1016/j.toxlet.2011.07.007
|
|
16162
Furuta RA, Miyazawa T, Sugiyama T, Kuratsune H, Ikeda Y, Sato E, Misawa N, Nakatomi Y, Sakuma R, Yasui K, Yamaguti K, Hirayama F.
No association of xenotropic murine leukemia virus-related virus with prostate cancer or chronic fatigue syndrome in Japan
Retrovirology
2011
8:20
PubMed ID: 21414229
DOI: 10.1186/1742-4690-8-20
|
|
8419
Fukushima K, Satoh T, Baba S, Yamashita K.
alpha1,2-Fucosylated and beta-N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer.
Glycobiology
2010
20:452-60
PubMed ID: 20008118
DOI: 10.1093/glycob/cwp197
|
|
10094
Fischer P, Kipp W, Bamuhiga J, Binta-Kahwa J, Kiefer A, Büttner DW.
Parasitological and clinical characterization of Simulium neavei-transmitted onchocerciasis in western Uganda.
Trop. Med. Parasitol.
1993
44:311-21
PubMed ID: 8134773
|
戻る
細胞材料の再培養方法 (
HPS以外・
HPS )
ページトップへ
細胞材料開発室サイト
